Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNMX vs. FHLC: which is better?

Bottom line

GNMX vs FHLC: the short answer

GNMX (Corgi Genomics & Precision Medicine ETF) and FHLC (Fidelity MSCI Health Care Index ETF) are both etfs.

Updated Nov 19, 2026

GNMX vs FHLC side by side

GNMXFHLC
TypeETFETF
Fund familyCorgi Genomics & Precision MedicineFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.084%
Annual cost per $10k—$8.4
10-yr cost on $10k (prospectus)—$108
Max front loadNoneNone
12b-1 fee—0%
1-yr return—+2.6%
5-yr return (annualized)—+7.2%
10-yr return (annualized)—+8.8%
Best quarter—+16.4%
Worst quarter—−13.1%
Net assets (fund)—$3.3B
Number of holdings—337
Portfolio turnover—3%
Returns as of—Nov 30, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GNMX and FHLC share none of their top holdings.

GNMX top 10

    FHLC top 10

    1. Eli Lilly & Co — 13.35%
    2. Johnson & Johnson — 8.93%
    3. AbbVie Inc — 6.42%
    4. UnitedHealth Group Inc — 5.44%
    5. Merck & Co Inc — 4.66%
    6. Thermo Fisher Scientific Inc — 3.09%
    7. Amgen Inc — 3.00%
    8. Abbott Laboratories — 2.66%
    9. Gilead Sciences Inc — 2.34%
    10. Pfizer Inc — 2.06%

    FAQ

    What is the difference between GNMX and FHLC?
    GNMX (Corgi Genomics & Precision Medicine ETF) and FHLC (Fidelity MSCI Health Care Index ETF) are both etfs.
    Should I own both GNMX and FHLC?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.